Review Article
Adjuvant Treatment of Melanoma
Table 8
Final results of study EORTC 18961 [
26].
| |
RFS |
DMFS |
OS | | OBS | GM2-KLH/QS-21 | OBS | GM2-KLH/QS-21 | OBS | GM2-KLH/QS-21 |
| No. of events | 204 | 205 | 143 | 152 | 112 | 124 | 4 yr% (SE%) | 69.4% (1.9%) | 68.2% (1.9%) | 78.8% (1.7%) | 76.1% (1.8%) | 83.6% (1.6%) | 81.5% (1.6%) | HR (95% CI)* | 1.03 (0.84, 1.25) | 1.11 (0.88, 1.40) | 1.16 (0.90, 1.51) | P value* | 0.81 | 0.36 | 0.26 |
|
|
HR: hazard ratio. *Cox model: stratified for stratification factors. OBS: observation. RFS: relapse-free survival. DMFS: distant metastasis-free survival. OS: overall survival.
|